Addus HomeCare screens attractively on valuation at a forward price-to-earnings of 12.7x and PEG of 0.91, carries a perfect Piotroski financial health score of 9 out of 9, and has delivered four consecutive earnings beats, while improving technical momentum — rising on-balance volume and improving MACD — and 21.7% upside to the analyst consensus target set up a reward-to-risk ratio of roughly 3.8-to-1.
Thesis pillars
- Attractive Valuation Top Financial Health→Stable
- Perfect Earnings Beat Streak→Stable
- Improving Momentum Volume Accumulation↑Improving
- +1 more pillar — see the Why tab for full reasoning
Pillars as of Jul 3, 2026, based on the 10-K filed Feb 24, 2026
Addus HomeCare Corporation (ADUS) Stock Analysis
Healthcare · Medical Care Facilities
Hold if already holding. Not a fresh buy at $122.18, but acceptable to hold if already in. Reasons: Analyst target reached - limited upside remaining; Near 52-week high (1.8% away).
Addus HomeCare Corporation operates three segments—personal care, hospice, and home health—serving approximately 107,000 consumers across 23 states through 262 offices as of December 31, 2025. Total net service revenue was $1.422 billion in 2025, predominantly funded by... Read more
Hold if already holding. Not a fresh buy at $122.18, but acceptable to hold if already in. Reasons: Analyst target reached - limited upside remaining; Near 52-week high (1.8% away). Chart setup: No clear chart pattern; technical signals are mixed. Maintain position. Not compelling to add more. Score 6.0/10, moderate confidence.
Passes 6/8 gates (positive momentum, clean insider activity, no SEC red flags, news events none recent, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio and earnings proximity 5d<=7d. Suitability: aggressive.
About Addus HomeCare Corporation
About Addus HomeCare Corporation
Addus HomeCare Corporation provided home-based personal care, hospice, and home health services to approximately 107,000 discrete consumers across 23 states through 262 offices during 2025, generating $1.422 billion in total net service revenue. Personal care—non-medical assistance with activities of daily living for the elderly and disabled—contributed $1.089 billion (77%) of segment revenues, hospice $262.5 million (18%), and home health $70.8 million (5%).
Addus derives revenue through hourly fee-for-service agreements with state and local government agencies, managed care organizations, and commercial insurers. For 2025, approximately 39.3% of net service revenues came from state and local governmental agencies (primarily Medicaid) and 20.5% from Medicare. As states shift from direct fee-for-service Medicaid administration to managed care models, managed care organizations represent an increasing share of the personal care payor mix. Agreements with state and local agencies carry initial terms of one to two years, terminable with 60 days' notice, and are typically renewed for one to five-year terms. Addus's workforce included approximately 34.5% union-represented employees—predominantly through local SEIU affiliates—as of December 31, 2025, subjecting the company to periodic collective bargaining; labor costs are the most significant component of total expenditures. The company completed four acquisitions in 2025—Gold Horses LLC (October), Helping Hands Home Care Service, Inc. (August), Great Lakes Home Care Unlimited (March), and its Jacksonville affiliate (January)—contributing $11.8 million in 2025 revenues.
Show full overview
Revenue concentration in three states exposes Addus to outsized policy risk: Illinois contributed 37.0% of 2025 net service revenues, Texas 15.2%, and New Mexico 13.1%. The Illinois Department on Aging programs alone represented 18.1% of 2025 revenue, down from 21.0% in 2024; state officials have in the past attempted and may again propose reductions to spending by this department that restrict consumer eligibility or authorized service hours. The One Big Beautiful Budget Act, enacted July 4, 2025, introduced restrictions on Medicaid financing mechanisms—including limits on provider tax arrangements—expected to reduce federal Medicaid matching funds flowing to states, which could weigh on Addus's reimbursement rates across its largest markets.
See also: Healthcare · Medical Care Facilities
From Addus HomeCare Corporation's most recent 10-K filing, extracted June 9, 2026.
Recent developments
updated 2026-10-29Recent Developments — Addus HomeCare Corporation
Latest news
- NEWS Addus Homecare Corp (ADUS) Institutional Confidence - TradingKey — TradingKey neutral
- NEWS Addus Homecare Corp (ADUS) Valuation: PE, PB & Fair Value Analysis - TradingKey — TradingKey neutral
- NEWS Addus Homecare Corp (ADUS) Financial Health: Profitability & Balance Sheet Analysis - TradingKey — TradingKey neutral
- NEWS Addus Homecare Corp (ADUS) Institutional Confidence - tradingkey.com — tradingkey.com neutral
- NEWS Addus Homecare Corp (ADUS) Financial Health: Profitability & Balance Sheet Analysis - tradingkey.com — tradingkey.com neutral
Generated 2026-10-29T11:48:39Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Concentration Risks(10-K Item 1A)
- MEDIUMGeographicIllinois37%10-K Item 1A: 'we derived approximately 37.0% of our net service revenues from services provided in Illinois'
- LOWGeographicTexas15%10-K Item 1A: '15.2% from services provided in Texas'
- LOWGeographicNew Mexico13%10-K Item 1A: '13.1% from services provided in New Mexico'
- LOWCustomerIllinois Department on Aging18%10-K Item 1A: 'we derived approximately 18.1% and 21.0%, respectively, of our revenue from the Illinois Department on Aging programs'
- MEDIUMCustomerMedicaid state programs39%10-K Item 1A: 'we derived approximately 39.3% of our net service revenues from state and local governmental agencies, primarily through Medicaid state programs'
- LOWCustomerMedicare21%10-K Item 1A: 'Medicaid state programs and 20.5% from Medicare'
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
1 floor-breaker
Technicals below the gate floor. Component breakdown shows what dragged the score down.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Hold if already holding. Not a fresh buy at $122.18, but acceptable to hold if already in. Reasons: Analyst target reached - limited upside remaining; Near 52-week high (1.8% away). Chart setup: No clear chart pattern; technical signals are mixed. Maintain position. Not compelling to add more. Analyst target $116.65 reached (−4.5%), stop $117.06 (−4.4%), A.R:R -0.5:1. Score 6.0/10, moderate confidence.
Analyst target $116.65 reached (−4.5% from $122.18); no take-profit level is published. Analyst target $116.65 reached (−4.5%), stop $117.06 (−4.4%), A.R:R -0.5:1. Stop-loss: $117.06.
Analyst target reached - limited upside remaining; Near 52-week high (1.8% away); V7 low-quality RISK_OFF penalty: -0.5 (Q=5.2).
Addus HomeCare Corporation trades at a P/E of 21.4 (forward 16.3). TrendMatrix value score: 6.2/10. Verdict: Hold.
20 analysts cover ADUS with a consensus score of 4.0/5. Average price target: $134.
What does Addus HomeCare Corporation do?Addus HomeCare Corporation operates three segments—personal care, hospice, and home health—serving approximately...
Addus HomeCare Corporation operates three segments—personal care, hospice, and home health—serving approximately 107,000 consumers across 23 states through 262 offices as of December 31, 2025. Total net service revenue was $1.422 billion in 2025, predominantly funded by Medicaid, Medicare, and managed care organizations. The consumer base is predominantly dual-eligible (qualifying for both Medicare and Medicaid), with services provided primarily under agreements with government agencies.